A model for harmonizing flow cytometry in clinical trials

Area of Science:

• Immunology
• Clinical Trials
• Laboratory Medicine

Background:

• Flow cytometry is a powerful tool for monitoring immunological parameters.
• Challenges in sample handling, instrument setup, and data analysis hinder its widespread clinical trial application.
• Standardization across multiple sites is difficult to achieve.

Purpose of the Study:

• To address the complexities of flow cytometry in clinical trials.
• To evaluate the effectiveness of a central laboratory approach for immunological monitoring.
• To propose a solution for consistent and reliable flow cytometry data in clinical research.

Main Methods:

• A novel approach utilizing a central laboratory for flow cytometry analysis was implemented.
• Standardized protocols for sample handling, instrument calibration, and data acquisition were developed.
• Quality control measures were established to ensure data integrity and reproducibility.

Main Results:

• The central laboratory model successfully mitigated issues related to sample handling.
• Standardized instrument setup and data analysis procedures reduced variability.
• The approach facilitated consistent and reliable monitoring of immunological parameters.

Conclusions:

• A central laboratory model offers a viable solution to overcome flow cytometry complexities in clinical trials.
• This approach enhances the feasibility and reliability of immunological monitoring in research settings.
• Implementing standardized central laboratory workflows can improve the quality of clinical trial data.